// App-Quantinova.ai

MON-1072 : Circulating Receptor Activator of Nuclear Factor ?B Ligand and Osteoprotegerin in Prediabetes: Relationships to Cardiovascular Risk

Researchers

Presenter

  • Esra Tutal

Principal Investigators

  • Melia Karakose

  • Mustafa Sahin

  • Mustafa Caliskan

  • Bekir Ucan

  • Taner Demirci

  • Guelfer Oztuerk

  • Erman Cakal

  • Mustafa Ozbek

  • Tuncay Delibasi

Medical Centers

  • Diskapi Yildirim Beyazit Research Hospital, Ankara, Turkey

  • Diskapi Yildirim Beyazit Research Hospital, Ankara, Turkey

  • Ankara University School of Medicine, Pharmacology, Ankara, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Prediabetes

  • Type 2 diabetes mellitus

  • Diabetes

Biomarkers

  • Osteoprotegerin

  • Receptor activator of nuclear factor kappa-Β ligand

  • High sensitivity C-reactive protein

  • Interferon-gamma

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved